Huons휴온스
243070 · KOSDAQ · ₩243070 · 휴온스
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
₩51,995
vs the current price (₩17,030)
- Enterprise value
- ₩763B
- Equity value
- ₩623B
- WACC
- 6.2%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model is 205% away from today's price. A gap this size usually means the market expects something the past figures don't show yet, or the model leaves something out. What we can see:
- To match today's price of ₩17,030, the model needs an operating margin of 4.8% every year (it uses 8.1%).
- Or revenue growth −21.8 points a year higher than assumed in each of the 5 years.
- Today's P/E is 10.8× against a typical 10.3× over the last 10 years.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- ₩19,042
- +11.8%
- Base
- ₩51,995
- +205.3%
- Bull
- ₩115,421
- +577.8%
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (8.1%).
Revenue growth
- 8%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (8% a year, annual reports), fading to 3% by year 5.
- 6.8%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (8% a year, annual reports), fading to 3% by year 5.
- 5.5%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (8% a year, annual reports), fading to 3% by year 5.
- 4.3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (8% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (8% a year, annual reports), fading to 3% by year 5.
Business
- 8.1%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 7%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).
- 8.8%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- 22%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.08%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-29.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 105 weeks of weekly returns against KOSPI (official index); raw beta 0.18, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.58%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩608B
- Net debt (borrowings and leases − cash and deposits)
- ₩110B
- + Stakes and investments
- ₩6.9B
- Associates, long-term financial assets and deposits (book value)
- − Minority interests
- ₩37B
- Shares
- 11,979,665
- Share price
- ₩17,030
- Market cap
- ₩204B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩552B | ₩590B | ₩621B | ₩656B | ₩701B | ₩740B | ₩771B | ₩795B |
| Growth | 12.1% | 6.9% | 5.2% | 8.0% | 6.8% | 5.5% | 4.3% | 3.0% |
| EBIT | ₩56B | ₩40B | ₩46B | ₩53B | ₩57B | ₩60B | ₩62B | ₩64B |
| EBIT margin | 10.1% | 6.7% | 7.3% | 8.1% | 8.1% | 8.1% | 8.1% | 8.1% |
| After-tax EBIT | ₩41B | ₩29B | ₩33B | ₩39B | ₩41B | ₩43B | ₩45B | ₩47B |
| + Depreciation | — | — | — | ₩46B | ₩49B | ₩52B | ₩54B | ₩56B |
| − Capital spending | ₩45B | ₩84B | ₩24B | ₩58B | ₩62B | ₩65B | ₩68B | ₩70B |
| − Working capital | ₩1.1B | ₩5.7B | ₩36B | ₩11B | ₩9.8B | ₩8.5B | ₩7B | ₩5.1B |
| Free cash flow | — | — | — | ₩16B | ₩19B | ₩22B | ₩24B | ₩27B |
| Discount factor | — | — | — | 0.942 | 0.886 | 0.835 | 0.786 | 0.740 |
| Present value | — | — | — | ₩15B | ₩17B | ₩18B | ₩19B | ₩20B |
Terminal value ₩911B, worth ₩674B today: 88% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩30,749 a share)Now 0.55× | ₩26,1390.85× | ₩38,5411.25× | ₩57,3301.86× |
| Price / earnings (last 12 months: ₩1,575 a share)Now 10.8× | ₩12,9208.21× | ₩16,22410.3× | ₩26,64216.9× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 5.2% | ₩57,081 | ₩64,112 | ₩73,315 | ₩85,892 | ₩104,133 |
| 5.7% | ₩49,201 | ₩54,499 | ₩61,210 | ₩69,995 | ₩82,000 |
| 6.2% | ₩42,845 | ₩46,940 | ₩51,995 | ₩58,397 | ₩66,776 |
| 6.7% | ₩37,615 | ₩40,844 | ₩44,748 | ₩49,566 | ₩55,669 |
| 7.2% | ₩33,236 | ₩35,826 | ₩38,902 | ₩42,621 | ₩47,211 |
Now (TTM)
- Market cap
- ₩204B
- Enterprise value
- ₩312B
- P/E
- 10.8×
- P/B
- 0.6×
- P/S
- 0.3×
- EV/EBITDA
- —
- Dividend yield
- 5.4%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Price | ₩27,400 | ₩27,400 | ₩38,400 | ₩29,150 | ₩47,700 |
| Market cap | ₩328B | ₩328B | ₩460B | ₩349B | ₩571B |
| P/E | 7.7× | 11.1× | 9.1× | 15.6× | 18.6× |
| P/B | 0.9× | 0.9× | 1.4× | 1.2× | 2.1× |
| P/S | 0.5× | 0.6× | 0.8× | 0.7× | 1.3× |
| EV/EBITDA | — | — | — | — | — |
| Dividend yield | 3.4% | 2.3% | — | — | — |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| Huons | 10.8× | 0.6× | 0.3× | — | 5.4% |
| Samsung Biologics | 31.9× | 7.6× | 13.9× | — | 0.0% |
| Celltrion | 27.9× | 2.5× | 9.0× | — | 0.0% |
| Alteogen | 79.4× | 28.6× | 60.3× | — | 0.1% |
| SK biopharmaceuticals | 15.2× | 6.0× | 7.1× | — | 0.0% |
| Yuhan | 23.2× | 2.3× | 2.4× | 30.2× | 0.8% |
| HLB | — | 15.4× | 54.3× | — | 0.0% |
| Similar companies (median) | 27.9× | 6.8× | 11.4× | 30.2× | 0.0% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: Huons / 휴온스 / 243070 / KRX:243070
Source: KRX statistical information